BU
DGX icon

BBVA USA’s Quest Diagnostics DGX Stock Holding History

BBVA USA’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$33K Sell
228
-41
-15% -$6K ﹤0.01% 722
2021
Q2 		$35K Buy
+269
New +$35.2K ﹤0.01% 724

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BBVA USA's DGX Position: Q3 2021 in Review

BBVA USA reduced its Quest Diagnostics (DGX) stake by 15% in Q3 2021, selling an estimated $6K and leaving 228 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #722.

BBVA USA first reported a position in DGX in Q2 2021 and has held it in 2 quarters since. The position peaked at $35K in Q2 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

  • BBVA USA held 228 shares of Quest Diagnostics worth $33K as of Q3 2021.
  • BBVA USA sold 41 Quest Diagnostics shares in Q3 2021, an estimated $6K.
  • Quest Diagnostics made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #722 holding.
  • BBVA USA first reported a position in Quest Diagnostics in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Quest Diagnostics position peaked at $35K in Q2 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.